https://socictopen.socict.org/files/original/a028886780581e7d73521183f15f31bf.pdf c6ef851e18170650a76c9e4e9e0b301a Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource New possibilities of therapy and prevention of complications of infectious-inflammatory diseases of the upper respiratory tract Creator An entity primarily responsible for making the resource A. A. Krivopalov, S.V. Ryazantsev, V. A. Shatalov Description An account of the resource Abstract. SARS in the overwhelming majority of cases are the initial link in the chain of pathological changes developing in acute rhinosinusitis, contribute to the severe course of the inflammatory process, development of local, remote and generalized complications. One of the important reasons for the growth of pathology of respiratory organs is increase of the prevalence of secondary immunodeficiencies (SIDS).The purpose of the study is to assess the effectiveness of the drug ISMIGEN® (sublingual tablets) on the course and severity of acute exacerbations of chronic tonsillopharyngitis during the epidemiological season of acute respiratory infections. Study design. This study is a comparative randomized, prospective, cohort trial. All patients matching the inclusion criteria and included in the study were randomized into 2 groups by 30 persons in accordance with the plan of randomization. The duration of the observation period was 6 months.Conclusions. Use of the drug Ismigen® allows significantly reduction of the likelihood of development in the patient of relapse/ exacerbation of HTF/SARS, the development of moderate and severe forms of the disease, as well as the need for additional antibiotic therapy. Date A point or period of time associated with an event in the lifecycle of the resource 2016 Subject The topic of the resource infectious-inflammatory diseases of the upper respiratory tract, complications of chronic tonsillopharyngitis, bacterial lysates, ismigen® Identifier An unambiguous reference to the resource within a given context DOI: 10.21518/2079-701X-2016-18-24-32 Source A related resource from which the described resource is derived Медицинский совет Publisher An entity responsible for making the resource available Remedium Group LLC Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Medicine Language A language of the resource RU